![](https://investorshub.advfn.com/uicon/756606.png?cb=1653487878)
Monday, July 18, 2022 11:21:55 AM
Bava 2-jab vaccine (US: Jynneos/ EU: Imvanex) is not the great elixir as believed. It's dicey.
https://www.mayoclinic.org/drugs-supplements/smallpox-monkeypox-vaccine-live-non-replicating-subcutaneous-route/side-effects/drg-20473664?p=1
-Bava vaccine (US: Jynneos/ EU: Imvanex). "Appropriate studies have not been performed on the relationship of age to the effects of smallpox monkeypox vaccine, live non-replicating, in the pediatric population. Safety and efficacy have not been established."
-Bava vaccine (US: Jynneos/ EU: Imvanex), "This vaccine may not protect everyone who receives it."
-Bava vaccine (US: Jynneos/ EU: Imvanex). "Appropriate studies have not been performed on the relationship of age to the effects of smallpox monkeypox vaccine, live non-replicating in the elderly 65 years of age and older. Safety and efficacy have not been established."
-Bava vaccine (US: Jynneos/ EU: Imvanex). "There are no adequate studies in women for determining infant risk when using this medication during breastfeeding."
-Bava vaccine (US: Jynneos/ EU: Imvanex) "This vaccine may cause a serious allergic reaction, including anaphylaxis, which can be life-threatening and requires immediate medical attention. Call your doctor right away if you have a rash, itching, hoarseness, trouble breathing, trouble swallowing, or any swelling of your hands, face, or mouth after you receive the vaccine.
-Bava vaccine (US: Jynneos/ EU: Imvanex) known side effects: "Chills, cough, difficulty with swallowing, dizziness, fast heartbeat, hives, itching, rash, puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue, tightness in the chest, troubled breathing, unusual tiredness or weakness, bleeding, blistering, burning, coldness, discoloration of the skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site, headache, muscle pai, nausea."
End quote
--------------------------------------------------------------------------------------------------------
$SIGA
Recent SIGA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:28:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:23:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:21:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:18:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:16:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:13:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:11:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:08:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:05:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:58:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:06:24 PM
- SIGA Reports Financial Results for Three Months Ended March 31, 2024 • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- SIGA Technologies to Host Business Update Call on May 7 Following Release of First-Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/01/2024 09:00:00 PM
- SIGA Amends International Promotion Agreement with Meridian to Enhance International Growth Opportunities of Oral TPOXX® • GlobeNewswire Inc. • 04/01/2024 08:05:00 PM
- SIGA Names Larry Miller General Counsel • GlobeNewswire Inc. • 03/25/2024 11:30:00 AM
- SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2023 • GlobeNewswire Inc. • 03/12/2024 08:05:00 PM
- SIGA Declares Special Cash Dividend of $0.60 Per Share • GlobeNewswire Inc. • 03/12/2024 11:30:00 AM
- SIGA Technologies to Host Business Update Call on March 12th, 2024 Following Release of Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 03/05/2024 12:30:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/01/2024 08:54:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:04:04 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 01/30/2024 10:01:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:01:28 PM
- SIGA Announces Appointment of Diem Nguyen, Ph.D., MBA, as New Chief Executive Officer • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 01:49:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2023 10:00:18 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM